Sueta D, Yamashita Y, Morimoto T, Chatani R, et al. Edoxaban, Rivaroxaban or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2. Thromb Haemost 2024 Apr 29. doi: 10.1055/a-2316-5269.
PMID: 38684190